Conduct trial with additional safety arm of 1800 subjects: CDSCO Panel Tells Bharath Biotech on Cholera Vaccine Dr. Divya Colin10 Jan 2023 6:00 PM ISTNew Delhi: Regarding the already approved Phase III clinical trial protocol of Cholera Vaccine (Inactivated Vibrio cholarae, MS 1568, Oral), the...
Bharat Biotech partner Ocugen announces positive top-line data for COVID vaccine Covaxin Ruchika Sharma10 Jan 2023 12:40 PM ISTCOVAXINâ„¢ is a highly purified and inactivated vaccine that is manufactured using a vero cell manufacturing platform.
Bharat Biotech INCOVACC to cost Rs 800 for Private hospitals, Rs 325 for Govt Isra Zaman28 Dec 2022 4:52 PM ISTBharat Biotech International Limited on Tuesday said its COVID-19 intranasal vaccine iNCOVACC, which is now available on CoWIN portal, is priced at Rs...
Health Bulletin 28/December/2022 Isra Zaman28 Dec 2022 4:36 PM ISTHere are the top health stories for the day:Bharat Biotech's iNCOVACC: India's 1st intranasal vaccine to cost Rs 800 in private markets, Rs 325 for...
Bharat Biotech, Biological E together hold about 250 million COVID vaccine doses Ruchika Sharma28 Dec 2022 2:43 PM ISTBharat Biotech sources said the vaccine maker has more than 50 million doses of Covaxin readily available in vials, and over 200 million doses as drug...
COVID intranasal vaccine: Bharat Biotech iNCOVACC priced at Rs 800 for private hospitals, Rs 325 for Govt Ruchika Sharma27 Dec 2022 2:30 PM ISTiNCOVACC is the world's first intranasal vaccine for COVID to receive approval for the primary two-dose schedule, and as a heterologous booster dose.
Health Bulletin 24/ December/ 2022 Roshni Dhar24 Dec 2022 4:32 PM ISTHere are the top health stories for the day:Fully prepared to deal with any eventuality, say Delhi hospitals amid coronavirus scareAmid concerns over...
Centre nod to Bharat Biotech nasal COVID vaccine iNCOVACC, to be availabile in private hospitals Ruchika Sharma23 Dec 2022 3:31 PM ISTiNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized SARS-CoV-2 spike protein.
Include intranasal COVID vaccine iNCOVACC in CoWIN portal: Bharat Biotech urges Centre Ruchika Sharma12 Dec 2022 12:30 PM ISTCurrently, Bharat Biotech's Covaxin, Serum Institute's Covishield and Covovax, Russian Sputink V, and Biological E Ltd's Corbevax are listed in the...
CCI approves proposed deal of Bharat Biotech International to acquire Eastman Exports shares Ruchika Sharma6 Dec 2022 11:39 AM IST"Given that there are no horizontal overlaps, vertical and/or complementary links between the activities of the BBIL (including its affiliates) and...
CDSCO nod to World's first intra-nasal COVID vaccine for restricted use Ruchika Sharma2 Dec 2022 12:00 PM ISTVaccine is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilized spike protein.
DCGI gives nod to Bharat Biotech Intranasal 'Five Arms' COVID booster dose for restricted use Ruchika Sharma26 Nov 2022 11:30 AM ISTThe nasal vaccine can be taken after six months of the second dose. As this is non-invasive and needle-free, it becomes easy to administer.
